|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
10
|
|
pubmed:dateCreated |
2010-9-22
|
|
pubmed:abstractText |
Cancer cells are thought to possess immune evasion properties due to FasL overexpression in many types of human tumors. In the present study, we set out to investigate the role of MAPK-ERK pathway in 67-kDa laminin receptor induced FasL expression and FasL-mediated apoptosis in human cholangiocarcinoma cells.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Enzyme Inhibitors,
http://linkedlifedata.com/resource/pubmed/chemical/Extracellular Signal-Regulated MAP...,
http://linkedlifedata.com/resource/pubmed/chemical/FASLG protein, human,
http://linkedlifedata.com/resource/pubmed/chemical/Fas Ligand Protein,
http://linkedlifedata.com/resource/pubmed/chemical/Flavonoids,
http://linkedlifedata.com/resource/pubmed/chemical/Lamr1 protein, human,
http://linkedlifedata.com/resource/pubmed/chemical/Luciferases,
http://linkedlifedata.com/resource/pubmed/chemical/MYC protein, human,
http://linkedlifedata.com/resource/pubmed/chemical/PD 98059,
http://linkedlifedata.com/resource/pubmed/chemical/Proto-Oncogene Proteins c-myc,
http://linkedlifedata.com/resource/pubmed/chemical/RNA, Small Interfering,
http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Laminin
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Oct
|
|
pubmed:issn |
1573-2568
|
|
pubmed:author |
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
55
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
2844-52
|
|
pubmed:meshHeading |
pubmed-meshheading:20101459-Apoptosis,
pubmed-meshheading:20101459-Bile Duct Neoplasms,
pubmed-meshheading:20101459-Bile Ducts, Intrahepatic,
pubmed-meshheading:20101459-Cholangiocarcinoma,
pubmed-meshheading:20101459-Coculture Techniques,
pubmed-meshheading:20101459-Enzyme Inhibitors,
pubmed-meshheading:20101459-Extracellular Signal-Regulated MAP Kinases,
pubmed-meshheading:20101459-Fas Ligand Protein,
pubmed-meshheading:20101459-Flavonoids,
pubmed-meshheading:20101459-Gene Expression Regulation, Neoplastic,
pubmed-meshheading:20101459-Humans,
pubmed-meshheading:20101459-Jurkat Cells,
pubmed-meshheading:20101459-Luciferases,
pubmed-meshheading:20101459-MAP Kinase Signaling System,
pubmed-meshheading:20101459-Promoter Regions, Genetic,
pubmed-meshheading:20101459-Proto-Oncogene Proteins c-myc,
pubmed-meshheading:20101459-RNA, Small Interfering,
pubmed-meshheading:20101459-Receptors, Laminin,
pubmed-meshheading:20101459-Transfection,
pubmed-meshheading:20101459-Up-Regulation
|
|
pubmed:year |
2010
|
|
pubmed:articleTitle |
The role of MAPK-ERK pathway in 67-kDa laminin receptor-induced FasL expression in human cholangiocarcinoma cells.
|
|
pubmed:affiliation |
Hepatobiliary Surgery Hospital and Institute, Southwest Hospital, Third Military Medical University, 400038, Chongqing, China.
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
